The Latin America, Middle East and Africa Non-steroidal Anti-inflammatory Drugs Market would witness market growth of 8.3% CAGR during the forecast period (2022-2028).
The analgesic impact of non NSAIDs are equivalent to those of first opioid dosages in acute situations. While greater doses do mediate anti-inflammatory benefits, unlike opioids, NSAIDs have a maximum dose above that no additional pain reduction occurs. Non-aspirin NSAIDs are similar to aspirin in lowering joint swelling, pain, and morning stiffness as well as in enhancing strength and mobility, according to clinical investigations in individuals with arthritis. Diclofenac, which is a nonselective NSAID, and celecoxib, a COX-2-specific NSAID, both showed superior pain and stiffness alleviation in randomized, double-blind, controlled studies using acetaminophen as the comparison.
Inflammation has been recognized as a key player in the aetiology of OA and OA-related pain in an increasing body of research. To variable degrees, inflammatory cytokines & proteases are involved in the breakdown of joints and aggravation of nociception. Individual variations in the level of inflammation and vulnerability to nociception sensitization might, at least in part, account for why many patients with radiographically mild illness experience considerable pain while others with more severe joint degeneration experience less discomfort. Because of this, using analgesics with no anti-inflammatory effects in the joints, like acetaminophen, would only relieve pain without having any clinically useful anti-inflammatory effects.
There are many people across this region who are facing severe chronic pain due to various diseases and hence, doctors are increasingly suggesting NSAIDs. Along with that, there is surge in the investment done by governments in the healthcare sector, which would fuel the product demand.
Disorders of the musculoskeletal system are prevalent in the general population. One of the main reasons of disability in the UAE is lower back pain, which is also a primary source of disability. Few researches have examined the frequency of rheumatic illnesses in the general population in the Middle East. Several of these studies have discussed the frequency of various musculoskeletal conditions in the general population.
The Brazil market dominated the LAMEA Non-steroidal Anti-inflammatory Drugs Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $512.3 Million by 2028. The Argentina market is experiencing a CAGR of 8.9% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 8% during (2022 - 2028).
Based on Route of Administration, the market is segmented into Oral, Topical and Others. Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospital Pharmacy and Online Pharmacy. Based on Route of Disease Indication, the market is segmented into Arthritis, Migraine, Ophthalmic Diseases and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Non-steroidal Anti-inflammatory Drugs Market is Predict to reach $25.5 Billion by 2028, at a CAGR of 5.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Dr. Reddy’s Laboratories Ltd., Pfizer, Inc., GlaxoSmithKline PLC, Bayer AG, Teva Pharmaceuticals Industries Ltd., Eli Lilly And Company, Sanofi S.A., AstraZeneca PLC, Viatris, Inc., and Merck & Co., Inc.
Scope of the Study
Market Segments Covered in the Report:
By Route of Administration
By Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- Online Pharmacy
By Disease Indication
- Arthritis
- Migraine
- Ophthalmic Diseases
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Dr. Reddy’s Laboratories Ltd.
- Pfizer, Inc.
- GlaxoSmithKline PLC
- Bayer AG
- Teva Pharmaceuticals Industries Ltd.
- Eli Lilly And Company
- Sanofi S.A.
- AstraZeneca PLC
- Viatris, Inc.
- Merck & Co., Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Non-steroidal Anti-inflammatory Drugs Market, by Route of Administration
1.4.2 LAMEA Non-steroidal Anti-inflammatory Drugs Market, by Distribution Channel
1.4.3 LAMEA Non-steroidal Anti-inflammatory Drugs Market, by Disease Indication
1.4.4 LAMEA Non-steroidal Anti-inflammatory Drugs Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Recent Strategies deployed in Non-steroidal Anti-inflammatory Drugs Market
Chapter 4. LAMEA Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
4.1 LAMEA Oral Market by Country
4.2 LAMEA Topical Market by Country
4.3 LAMEA Others Market by Country
Chapter 5. LAMEA Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
5.1 LAMEA Retail Pharmacy Market by Country
5.2 LAMEA Hospital Pharmacy Market by Country
5.3 LAMEA Online Pharmacy Market by Country
Chapter 6. LAMEA Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
6.1 LAMEA Arthritis Market by Country
6.2 LAMEA Migraine Market by Country
6.3 LAMEA Ophthalmic Diseases Market by Country
6.4 LAMEA Others Market by Country
Chapter 7. LAMEA Non-steroidal Anti-inflammatory Drugs Market by Country
7.1 Brazil Non-steroidal Anti-inflammatory Drugs Market
7.1.1 Brazil Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
7.1.2 Brazil Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
7.1.3 Brazil Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
7.2 Argentina Non-steroidal Anti-inflammatory Drugs Market
7.2.1 Argentina Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
7.2.2 Argentina Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
7.2.3 Argentina Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
7.3 UAE Non-steroidal Anti-inflammatory Drugs Market
7.3.1 UAE Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
7.3.2 UAE Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
7.3.3 UAE Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
7.4 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market
7.4.1 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
7.4.2 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
7.4.3 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
7.5 South Africa Non-steroidal Anti-inflammatory Drugs Market
7.5.1 South Africa Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
7.5.2 South Africa Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
7.5.3 South Africa Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
7.6 Nigeria Non-steroidal Anti-inflammatory Drugs Market
7.6.1 Nigeria Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
7.6.2 Nigeria Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
7.6.3 Nigeria Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
7.7 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market
7.7.1 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market by Route of Administration
7.7.2 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel
7.7.3 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market by Disease Indication
Chapter 8. Company Profiles
8.1 Dr. Reddy’s Laboratories Ltd.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.2 Pfizer, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional & Segmental Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Approvals and Trails:
8.3 GlaxoSmithKline PLC
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Approvals and Trails:
8.4 Bayer AG
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Approvals and Trails:
8.5 Teva Pharmaceutical Industries Ltd.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.6 Eli Lilly And Company
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Approvals and Trails:
8.7 Sanofi S.A.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.8 AstraZeneca PLC
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expenses
8.9 Viatris, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.10. Merck & Co., Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expenses
TABLE 1 LAMEA Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 3 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 4 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 5 LAMEA Oral Market by Country, 2018 - 2021, USD Million
TABLE 6 LAMEA Oral Market by Country, 2022 - 2028, USD Million
TABLE 7 LAMEA Topical Market by Country, 2018 - 2021, USD Million
TABLE 8 LAMEA Topical Market by Country, 2022 - 2028, USD Million
TABLE 9 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 10 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 11 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 12 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 13 LAMEA Retail Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 14 LAMEA Retail Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 15 LAMEA Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 16 LAMEA Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 17 LAMEA Online Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 18 LAMEA Online Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 19 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 20 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 21 LAMEA Arthritis Market by Country, 2018 - 2021, USD Million
TABLE 22 LAMEA Arthritis Market by Country, 2022 - 2028, USD Million
TABLE 23 LAMEA Migraine Market by Country, 2018 - 2021, USD Million
TABLE 24 LAMEA Migraine Market by Country, 2022 - 2028, USD Million
TABLE 25 LAMEA Ophthalmic Diseases Market by Country, 2018 - 2021, USD Million
TABLE 26 LAMEA Ophthalmic Diseases Market by Country, 2022 - 2028, USD Million
TABLE 27 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 28 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 29 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Country, 2018 - 2021, USD Million
TABLE 30 LAMEA Non-steroidal Anti-inflammatory Drugs Market by Country, 2022 - 2028, USD Million
TABLE 31 Brazil Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 32 Brazil Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 33 Brazil Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 34 Brazil Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 35 Brazil Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 36 Brazil Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 37 Brazil Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 38 Brazil Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 39 Argentina Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 40 Argentina Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 41 Argentina Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 42 Argentina Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 43 Argentina Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 44 Argentina Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 45 Argentina Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 46 Argentina Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 47 UAE Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 48 UAE Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 49 UAE Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 50 UAE Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 51 UAE Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 52 UAE Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 53 UAE Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 54 UAE Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 55 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 56 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 57 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 58 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 59 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 60 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 61 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 62 Saudi Arabia Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 63 South Africa Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 64 South Africa Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 65 South Africa Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 66 South Africa Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 67 South Africa Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 68 South Africa Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 69 South Africa Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 70 South Africa Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 71 Nigeria Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 72 Nigeria Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 73 Nigeria Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 74 Nigeria Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 75 Nigeria Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 76 Nigeria Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 77 Nigeria Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 78 Nigeria Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 79 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market, 2018 - 2021, USD Million
TABLE 80 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market, 2022 - 2028, USD Million
TABLE 81 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 82 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 83 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 84 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 85 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2018 - 2021, USD Million
TABLE 86 Rest of LAMEA Non-steroidal Anti-inflammatory Drugs Market by Disease Indication, 2022 - 2028, USD Million
TABLE 87 key information – Dr. Reddy’s Laboratories Ltd.
TABLE 88 Key Information – Pfizer, Inc.
TABLE 89 Key Information – GlaxoSmithKline PLC
TABLE 90 Key Information – Bayer AG
TABLE 91 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 92 Key Information – Eli Lilly And Company
TABLE 93 Key Information – Sanofi S.A.
TABLE 94 KEY INFORMATION – ASTRAZENECA PLC
TABLE 95 key information – Viatris, Inc.
TABLE 96 KEY INFORMATION - MERCK & CO., INC.
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Dr. Reddy’s Laboratories Ltd.